Literature DB >> 8464435

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

W C Black1, H G Welch.   

Abstract

Mesh:

Year:  1993        PMID: 8464435     DOI: 10.1056/NEJM199304293281706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  106 in total

1.  Psychological and screening profiles of first-degree relatives of prostate cancer patients.

Authors:  S M Miller; M A Diefenbach; L K Kruus; D Watkins-Bruner; G E Hanks; P F Engstrom
Journal:  J Behav Med       Date:  2001-06

Review 2.  On the value-ladenness of technology in medicine.

Authors:  B Hofmann
Journal:  Med Health Care Philos       Date:  2001

3.  Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice.

Authors:  A Gilead; M Neeman
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

4.  Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors:  Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 5.  The significance of quality of life in health care.

Authors:  Robert M Kaplan
Journal:  Qual Life Res       Date:  2003       Impact factor: 4.147

Review 6.  Use of decision aids to support informed choices about screening.

Authors:  Alexandra Barratt; Lyndal Trevena; Heather M Davey; Kirsten McCaffery
Journal:  BMJ       Date:  2004-08-28

7.  Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?

Authors:  Megan R Haymart; David C Miller; Sarah T Hawley
Journal:  N Engl J Med       Date:  2017-07-20       Impact factor: 91.245

Review 8.  Screening for cancer: valuable or not?

Authors:  Frank L Meyskens
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 9.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

10.  Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.

Authors:  Nathalie Magnus; Delphine Garnier; Brian Meehan; Serge McGraw; Tae Hoon Lee; Maxime Caron; Guillaume Bourque; Chloe Milsom; Nada Jabado; Jacquetta Trasler; Rafal Pawlinski; Nigel Mackman; Janusz Rak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.